Compounded
Semaglutide
Any prescribed dose up to 2.5 mg/week
Prescription & clinician review included
Shipping included
$948 due today
Back to All Reviews
Investigation Report
Strive Pharmacy Tirzepatide Review
Strive Compounding Pharmacy, strivepharmacy.com
Also spelled as Strive Compounding Pharmacy, strivepharmacy.com — Same brand, same great service!
Our investigation of Compounded Tirzepatide from Strive Pharmacy
Caution Advised
Multiple red flags identified
Caution Advised
Generally set by the prescribing telehealth provider or clinic rather than published by the pharmacy
100+
Hours Researched
7
Verified Pros
6
Issues Found
7
Final Score
These are Med Consumer Watch products, not products from Strive Pharmacy, the brand being reviewed on this page.
Med Consumer Watch GLP-1 plans
GLP-1 weight loss.
A brand on your side.
Med Consumer Watch exists to help consumers make informed choices. Our brand brings that mission to GLP-1 care: clear plan prices, clinician review and support included, so you can compare your options and get started with confidence.
Why choose Med Consumer Watch?
Know your full price
Medication, clinician review and shipping are included. See your total before you buy.
Same price at every included dose
Your plan price stays the same across its included prescribed doses. Choose 1, 3, 6 or 12 months.
Support beyond your prescription
Ongoing doctor messaging, health coaching and patient community access are included with your plan.
Choose your medication and the plan length that works for you.
Buy semaglutide
Compounded
Tirzepatide
Any prescribed dose up to 15 mg/week
Prescription & clinician review included
Shipping included
$1,548 due today
Treatment requires a prescription and clinician approval. If treatment is declined, your payment is refunded. Compounded medications are not FDA-approved.
Investigation Overview
Strive is a compounding pharmacy rather than a telehealth provider, and like Empower it is reviewed here because it is one of the names behind the compounded GLP-1 telehealth market. Our research (August 8, 2026) found the strongest accreditation record of any compounder we have examined, alongside one documented regulatory finding.
The Accreditation Is Genuinely Strong
Strive is a 503A compounding pharmacy headquartered in Gilbert, Arizona, and it holds an unusual combination of voluntary accreditations:- PCAB — the Pharmacy Compounding Accreditation Board
- NABP — the National Association of Boards of Pharmacy
- LegitScript
Quality Practices It Publishes
- Third-party testing for sterility, potency and endotoxins
- 90-day beyond-use dates on GLP-1 products
- Ingredients sourced exclusively from FDA-registered facilities on the GLP-1 "Green List," per its published quality standards
- All compounded medications require a prescription from a licensed healthcare provider
The Consent Agreement
In a February 2024 consent agreement, the Arizona State Board of Pharmacy recorded that Strive began compounding injectable semaglutide in August 2021 — approximately seven months before semaglutide was added to the FDA's drug shortage list. Strive agreed to pay a $1,000 fine. The fine is trivial. The fact is not, and it goes directly to the issue at the centre of this entire market. As our compounding guide explains, a shortage is what permits compounders to prepare copies of an approved drug that would otherwise be prohibited. Compounding semaglutide before any shortage existed means that permission was not available at the time. We are reporting a state board finding, not alleging patient harm — there is no suggestion in this record of contamination, potency failure or injury. It is a compliance matter, resolved, and years old. But it is a documented instance of compounding ahead of the legal basis for it, and a patient choosing between compounders is entitled to weigh it.Scale
In October 2024 Strive announced the acquisition of a nearly 50,000 square-foot facility in St. Louis, Missouri, intended for compounding, warehousing and fulfilment in a vertically integrated model designed to serve telehealth companies at scale. If you are buying compounded GLP-1s from a telehealth provider, this is a plausible origin.Our Investigation Summary
Our research (August 8, 2026) found Strive Pharmacy to have the strongest accreditation record of any compounder we have examined: a 503A compounding pharmacy in Gilbert, Arizona, voluntarily accredited by PCAB, NABP and LegitScript, licensed in all 50 states across nine locations. It publishes third-party testing for sterility, potency and endotoxins, 90-day beyond-use dates on GLP-1 products, and ingredient sourcing exclusively from FDA-registered facilities on the GLP-1 "Green List." Its formulations are combinations — Semaglutide/Glycine/B12 and Tirzepatide/Glycine/B12 — and all compounded medications require a prescription from a licensed provider. The documented finding: a February 2024 Arizona State Board of Pharmacy consent agreement recording that Strive began compounding injectable semaglutide in August 2021, approximately seven months before semaglutide was added to the FDA drug shortage list, with a $1,000 fine agreed. That is a compliance matter with no suggestion of patient harm, but it concerns compounding ahead of the shortage that would have provided the legal basis. In October 2024 Strive acquired a nearly 50,000 square-foot St. Louis facility built to serve telehealth companies at scale.
How Strive Pharmacy Works
1
Strive does not sell to patients without a prescription — all compounded medications require one from a licensed healthcare provider
2
It operates both direct patient fulfilment and provider partnerships, so your telehealth provider may route your prescription here
3
GLP-1 formulations are combination preparations: Semaglutide/Glycine/B12 or Tirzepatide/Glycine/B12
4
Products carry a 90-day beyond-use date and third-party testing for sterility, potency and endotoxins
5
To find out whether your medication comes from here, ask your provider which pharmacy fills your prescription
6
If it is Strive, you can verify its PCAB, NABP and LegitScript accreditations independently
What We Found
What's Good
- Voluntarily accredited by PCAB, NABP and LegitScript — an unusually strong combination for a 503A pharmacy
- Licensed in all 50 states across nine locations, among the most expansive 503A operations in GLP-1 compounding
- Publishes third-party testing for sterility, potency and endotoxins — endotoxin testing being the right test for an injectable
- Publishes a 90-day beyond-use date on GLP-1 products, which most compounders do not disclose
- States that ingredients are sourced exclusively from FDA-registered facilities on the GLP-1 'Green List'
- Requires a prescription from a licensed healthcare provider for all compounded medications
- Substantial, verifiable operation with a named headquarters and public accreditation records
Watch Out For
- A February 2024 Arizona Board of Pharmacy consent agreement records compounding of injectable semaglutide from August 2021 — about seven months before the FDA shortage listing
- As a 503A pharmacy it is state-board regulated rather than an FDA-registered facility subject to federal cGMP inspection
- GLP-1 products are combination preparations with glycine and B12, additives not present in the trialled drugs
- Compounded drugs are not FDA-approved and are not reviewed for safety, effectiveness or manufacturing quality
- Pricing to patients is generally set by the prescribing telehealth provider rather than published here
- 2026 restrictions on GLP-1 compounding apply, and the shortage-based justification has ended
Pricing Breakdown
Starting Price
Not applicable in most cases — pricing is generally set by the prescribing telehealth provider or clinic
Medication Cost
Varies by prescriber and formulation. GLP-1 products are Semaglutide/Glycine/B12 and Tirzepatide/Glycine/B12 combination preparations
Subscription Fees
None — this is a compounding pharmacy, not a consumer subscription service
Hidden Fees
Not applicable. The relevant cost question is what your telehealth provider charges
Safety & Medical Oversight
Strive is a 503A compounding pharmacy, meaning it is regulated primarily by state boards of pharmacy rather than being an FDA-registered facility subject to federal cGMP inspection — a distinction explained in our brand-name versus compounded guide. Within that pathway its quality signals are unusually strong: voluntary PCAB, NABP and LegitScript accreditation, third-party testing for sterility, potency and endotoxins, 90-day beyond-use dating on GLP-1 products, and ingredients sourced exclusively from FDA-registered facilities on the GLP-1 "Green List." Endotoxin testing is the correct test for an injectable and its publication is more than most compounders offer. Two things to weigh. First, its GLP-1 products are combination preparations containing glycine and B12 in addition to the active drug — those additives were not part of the clinical trials that established semaglutide and tirzepatide work. Second, a February 2024 Arizona State Board of Pharmacy consent agreement records that Strive began compounding injectable semaglutide in August 2021, roughly seven months before the FDA shortage listing that would have provided a legal basis; a $1,000 fine was agreed. That is a compliance record with no indication of patient harm. Compounded drugs are not FDA-approved and are not reviewed for safety, effectiveness or manufacturing quality before reaching patients.
Customer Support
Strive operates both direct patient fulfilment and provider partnerships, so the relationship depends on how your prescription was routed. All compounded medications require a prescription from a licensed healthcare provider. With nine locations and licensure in all 50 states, geographic reach is broad. The October 2024 acquisition of a nearly 50,000 square-foot St. Louis facility was explicitly framed around serving telehealth companies at scale, which suggests the primary relationship is business-to-business. If you have a question about a medication compounded here, your route is normally through the prescriber who ordered it.
Key Features
503A Compounding Pharmacy
PCAB, NABP & LegitScript Accredited
Licensed in All 50 States
Nine Locations
90-Day Beyond-Use Dating on GLP-1s
Third-Party Sterility, Potency & Endotoxin Testing
Semaglutide/Glycine/B12 & Tirzepatide/Glycine/B12
Prescription Required
Best For
Patients who have asked their telehealth provider which pharmacy fills their prescription and want to evaluate the answer — Strive's accreditations are independently verifiable
Customer Reviews & Complaints
Strive is a compounding pharmacy supplying prescribers and patients by prescription, so the meaningful record is regulatory and accreditation rather than consumer reviews. We reviewed public records as of August 8, 2026.
Accreditation: voluntary accreditation by PCAB (Pharmacy Compounding Accreditation Board), NABP (National Association of Boards of Pharmacy) and LegitScript, with licensure in all 50 states across nine locations. This is the strongest accreditation profile of any compounder we have examined for this site.
Published quality practices: third-party testing for sterility, potency and endotoxins; 90-day beyond-use dating on GLP-1 products; ingredients sourced exclusively from FDA-registered facilities on the GLP-1 "Green List."
The regulatory finding: a February 2024 Arizona State Board of Pharmacy consent agreement recorded that Strive began compounding injectable semaglutide in August 2021, approximately seven months before semaglutide was added to the FDA drug shortage list. A $1,000 fine was agreed.
How to weigh that: the penalty is nominal and there is no indication in the record of contamination, potency failure or patient harm. But a shortage is precisely what permits compounding copies of an approved drug, and compounding before one existed means that basis was absent. It is a resolved compliance matter from years ago, and it is a legitimate data point when choosing between compounders.
Scale: in October 2024 Strive announced acquisition of a nearly 50,000 square-foot St. Louis facility for vertically integrated compounding, warehousing and fulfilment, explicitly to serve telehealth companies at scale.
Is Strive Pharmacy Legit?
"Is Strive Pharmacy legitimate?" is a question patients usually ask after learning their telehealth provider routes prescriptions here. Our assessment as of August 8, 2026.
Official Verification: Strive is a real, licensed 503A compounding pharmacy headquartered in Gilbert, Arizona, licensed in all 50 states, with voluntary PCAB, NABP and LegitScript accreditation. Those accreditations are independently checkable, which is precisely why they are worth holding.
Within its regulatory category, the quality signals are strong. 503A pharmacies are state-board regulated rather than FDA-registered, so voluntary accreditation and published testing standards are among the few external checks available — and Strive has more of them than most. Publishing endotoxin testing and a 90-day beyond-use date on injectables is meaningfully more disclosure than the norm.
The consent agreement is the counterweight. Beginning to compound injectable semaglutide roughly seven months before the FDA shortage listing means doing so without the legal basis a shortage provides. It was resolved with a $1,000 fine in February 2024 and involves no allegation of harm — but it speaks to compliance posture at the time.
Red Flags Check:
- ✓ PCAB, NABP and LegitScript accredited — independently verifiable
- ✓ Licensed in all 50 states, nine locations
- ✓ Third-party sterility, potency and endotoxin testing published
- ✓ 90-day beyond-use dating published
- ✓ Ingredients from FDA-registered "Green List" facilities
- ✓ Prescription required for all compounded medications
- ⚠ February 2024 Arizona Board consent agreement, $1,000 fine
- ⚠ Compounded semaglutide from August 2021, before the shortage listing
- ⚠ 503A pathway is state-regulated, not FDA-inspected
- ⚠ Combination formulations include additives not present in trialled drugs
The Bottom Line: If your telehealth provider names Strive, that is a better answer than most — the accreditation stack is real and checkable, and the published testing standards exceed the category norm. Weigh the 2024 consent agreement as a compliance data point rather than a safety one, and remember that no accreditation makes a compounded drug FDA-approved. As always, discuss any concern about a medication you are taking with your prescribing clinician.
Our Verdict: Caution Advised
Strive Pharmacy has a 7/10 site score. We've identified some concerns that potential customers should be aware of. We recommend reviewing our top picks before proceeding.
Visit Strive PharmacyStrive Pharmacy
Caution Advised
7/10
Generally set by the prescribing telehealth provider or clinic rather than published by the pharmacy
Prescription treatment requires clinician review
Investigation Summary
Overall Rank#128 of 226
Rating7/10
StatusCaution Advised
PricingGenerally set by the prescribing telehealth provider or clinic rather than published by the pharmacy
Share Your Experience
Help others by sharing your experience with Strive Pharmacy
Want to compare options?
View All 226 ProvidersUser Reviews
Rating Summary
No ratings yet
Rate your experience
Click a star to rate and add a review
Questions & Discussions
226 Providers Reviewed
Explore Other Reviews
Compare with other GLP-1 weight loss providers we've investigated
Our Top Picks
Promotional placement: CoreAge Rx is featured #1 and SuperHealthy Rx #2. Placements and site scores are not independent clinical ratings or patient review averages. We may earn compensation from referral links. How our rankings work.
#1 RecommendedExcellent
#2 RecommendedExcellent
#3 RecommendedGreat
Mochi Health
8.8
Affordable GLP-1 Access Starting at $99/Month with No Long-Term Commitment
More Provider Reviews
CoreAge Rx
9.9
SuperHealthy Rx
9.7
Mochi Health
8.8
Remedy Meds
8.3
Caution Advised
Ready to Get Started with Strive Pharmacy?
Review our findings above and make an informed decision about Strive Pharmacy.
Enter to Win a $1,788 CoreAge Rx Gift Card
Enter for a chance to use it toward eligible CoreAge Rx products and services.
The gift card may be applied toward eligible CoreAge Rx products and services. Prescription products additionally require completing the intake process and evaluation by a licensed healthcare provider, who alone decides eligibility and treatment. Winning does not guarantee that you will qualify for a GLP-1 medication or any other prescription treatment.